Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP001470

Drug Information
NameDexamfetamine
Synonymsdextroamphetamine; D-Amphetamine; (2S)-(+)-Amphetamine; (+/-)-beta-Phenylisopropylamine; DB01576; CID5826; (S)-alpha-Phenylethylamine; S(+)-Amphetamine; DEA No. 1100; Simpatedrin; Dexamfetamine (INN); (S)-alpha-Methylphenethylamine; Raphetamine; Fenylo-izopropylaminyl; Sympamin; (S)-1-Phenyl-2-propylamine; Rhinalator; Phenethylamine, alpha-methyl-, d-; Propisamine; Benzedrine; dextro-Amphetamine; (+)-alpha-Methylphenylethylamine; CHEMBL612; (S)-Amphetamine; Dexamfetamina [INN-Spanish]; LS-187774; EINECS 200-112-1; Dexamfetaminum; D-alpha-methylphenethylamine; Dexamfetamine; alpha-Methylphenethylamine, d-form; Sympamine; Benzeneethanamine, alpha-methyl-, (S)-; D-(+)-Amphetamine; Dexamphetaminum; (S)-(+)-Amphetamine; PDSP2_001495; Dexidrine; (2S)-1-phenylpropan-2-amine; Phenethylamine, alpha-methyl-, (+)-; dl-1-Phenyl-2-aminopropane; D03740; Dextroamphetamine resin complex; MolPort-004-285-839; Isoamycin; (S)-1-Phenyl-2-propanamine; D-(S)-Amphetamine; Dexamphetaminum [INN-Latin]; dl-Benzedrine; (S)-(+)-beta-Phenylisopropylamine; Dexedrine Spansule; dl-Amphetamine; Desamfetamina [DCIT]; Dexamfetamina; (+/-)-Desoxynorephedrine; Benzeneethanamine, alpha-methyl-, (alphaS)-; AC1L1L85; (+/-)-Benzedrine; Dephadren; beta-phenyl-isopropylamine; Psychedrine; NCGC00168247-01; (+)-Phenaminum; PDSP1_001511; D-AM; Benzeneethanamine, alpha-methyl-, (aS)- (9CI); HSDB 3055; BRN 2205872; Dexadrine; NSC 73713; Dexedrine; Amsustain; Dextroamphetamine [USAN]; D-2-Amino-1-phenylpropane; D-1-Phenyl-2-aminopropane; Dexacaps; Dexamphetamine; C07884; Sympatedrine; d-1-Phenyl-2-aminopropan [German]; Dextro-Amphetamine Sulfate; (alphaS)-alpha-methylbenzeneethanamine; 4-12-00-02587 (Beilstein Handbook Reference); Dextroamphetamine (USAN); Dexanfetamina [INN-Spanish]; Desamfetamina; CHEBI:4469; (+)-(S)-Amphetamine; Dexanfetamina; (S)-alpha-methylbenzeneethanamine; Weckamine; Dexamfetaminum [INN-Latin]; 51-64-9; (S)-1-Phenyl-2-aminopropane; (+)-Amphetamine; (+)-alpha-Methylphenethylamine; D-1-Phenyl-2-aminopropan; DB00182; Phenethylamine, alpha-methyl-, (+)- (8CI); LS-103617; UNII-TZ47U051FI
IndicationAttention-deficit hyperactivity disorder
[ICD9: 314.0   ICD10: F90]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1
InChIKeyKWTSXDURSIMDCE-QMMMGPOBSA-N
Canonical SMILESCC(CC1=CC=CC=C1)N    
Isomeric SMILESC[C@@H](CC1=CC=CC=C1)N
CAS NumberCAS 51-63-8
PubChem Compound IDCID 5826.
PubChem Substance IDSID 10086.
ChEBI51064;
SuperDrug ATC IDN06BA02
SuperDrug CAS ID000051649;
TargetAlpha-2 adrenergic receptorAgonist[1]
Alpha-2 adrenergic receptorMultitarget[1]
D(2) dopamine receptor Agonist[1]
D(2) dopamine receptor Multitarget[1]
Ref 1Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry. 2009 Mar;194(3):273-7. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543